|Awarded On||February 16, 2022|
|Title||Quantitative NIRFLI scanning of lymphatic dysfunction in head and neck cancer patients for early diagnosis of cancer-acquired lymphedema|
|Award Mechanism||Individual Investigator|
|Institution/Organization||The University of Texas Health Science Center at Houston|
|Principal Investigator/Program Director||John Rasmussen|
|Cancer Sites||Head and Neck|
Head and neck cancers (HNCs) are the 7th most prevalence cancer worldwide, and despite the declining use of tobacco products associated with its incidence, the prevalence of human papillomavirus (HPV) may be the reason why HNC is rising world-wide and in the US. Treatment of HPV positive HNC is largely effective, but can involve lymph node dissection and radiation therapy, both of which cause head and neck lymphedema (HNL) in an estimated 75% of all HNC survivors. Akin to the well-known condition of breast cancer related lymphedema (BRCL) that causes irreversible swelling of arms, HNL can involve edema that manifests as external and internal swelling that can impair movement, speech, breathi...